Clinical trial
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Trial To Evaluate The Efficacy, Safety, and Pharmacokinetics of Ibuprofen Injection in Adult Febrile Patients
NCT01131000 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Trial To Evaluate The Efficacy, Safety, and Pharmacokinetics of Ibuprofen Injection in Adult Febrile Patients
- Lead sponsor
- Cumberland Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- August 31, 2005
- Enrollment
- 123 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.